NovoRapid® Vial for Mealtime Insulin Therapy

NovoRapid® is a rapid-acting insulin aspart 100 units/mL solution supplied as a 10 mL multidose vial. CanadianInsulin ships from Canada to the US with US delivery from Canada and Canadian pricing, which can help those paying without insurance. This page explains what it is, how it works, dosing basics, storage, safety, and how to order the NovoRapid vial online.

What NovoRapid® Is and How It Works

NovoRapid® (insulin aspart) is a rapid-acting insulin analog for mealtime blood sugar control. It helps cover carbohydrate intake and correct high readings in adults and children with diabetes, when prescribed.

CanadianInsulin connects patients with licensed Canadian pharmacies. Prescriptions are verified with your clinic before dispensing.

Insulin aspart has a small amino acid change that speeds absorption compared to regular human insulin. After subcutaneous injection, it begins working quickly to reduce glucose around meals. A mealtime dose is usually taken shortly before eating, or soon after the first bite when directed.

The NovoRapid 100 units/mL vial is for subcutaneous use with U-100 insulin syringes. It may also be used in compatible insulin pumps when allowed by labeling and prescriber guidance. For background on rapid mealtime insulins, see our editorial overview Fast Acting Insulin.

Who NovoRapid® Is For

This medicine is indicated for adults and pediatric patients who need rapid-acting insulin to manage type 1 diabetes or type 2 diabetes as part of a basal-bolus plan or pump therapy. It is not for treating diabetic ketoacidosis outside supervised care, and not for episodes of low blood sugar.

People with a known allergy to insulin aspart or formulation ingredients should not use it. Caution is advised with frequent hypoglycemia, changes in kidney or liver function, or during pregnancy and breastfeeding, under clinician guidance. To explore related therapies, see Rapid Acting Insulin Vials.

Dosage and Usage

Dosing is individualized. NovoRapid insulin aspart is commonly given shortly before a meal, or soon after starting a meal if directed. The dose may be based on carbohydrate counting, correction factors, and recent glucose results. Follow the treatment plan set by the prescriber.

Administration tips include rotating injection sites within the same region to reduce skin changes. Common areas are the abdomen, thigh, upper arm, or buttock. Avoid injecting into areas that are tender, damaged, thickened, or scarred.

For the vial, use only U-100 insulin syringes. Confirm that the solution is clear and colorless. The 10 mL vial contains a total of 1000 units. Do not share vials, syringes, or needles.

Insulin pumps can deliver insulin aspart continuously for basal coverage and boluses for meals. Use only with pump systems that specify insulin aspart, and follow pump manuals and clinical instructions. Do not mix insulin inside a pump reservoir.

Mixing in a syringe with other insulins should only be done if permitted by the label and prescriber instructions. If mixing with NPH for a single subcutaneous injection is recommended, follow the exact technique provided by the healthcare team.

Strengths and Forms

• Vial: 100 units/mL (U-100) in a 10 mL multidose vial.
• Cartridge: 100 units/mL (3 mL), for compatible reusable pens.
• Prefilled pen: 100 units/mL (3 mL), depending on market availability.

Availability can vary by dispensing pharmacy and region.

Missed Dose and Timing

If a mealtime dose is missed before eating, certain plans allow taking insulin aspart soon after starting the meal. If a dose is forgotten entirely, follow the individualized correction plan and check glucose more frequently. Avoid taking extra insulin without guidance. Timing rules can differ by patient plan; follow the prescriber’s instructions.

Storage and Travel Basics

Unopened vials are typically stored refrigerated at 2°C to 8°C (36°F to 46°F). Do not freeze. Keep away from heat and direct light.

Once in use, many patients store the vial at room temperature below 30°C (86°F) or refrigerated, and discard after the in-use period on the label. Always keep the cap on to protect from light. Do not use the insulin if it was frozen, overheated, or appears cloudy or colored.

For travel, carry supplies in hand luggage with a backup vial, syringes, and glucose monitoring tools. Keep the pharmacy label and a copy of the prescription with the medication. Use an insulated pouch to maintain a safe temperature range during trips.

Pen Handling and Sharps Disposal

This product is a vial used with U-100 insulin syringes. Draw the dose with a new sterile needle and syringe each time. Do not reuse needles. After injection, place used needles and syringes in an FDA-cleared sharps container or a puncture-resistant household container if a sharps container is not available. Follow local rules for disposal.

Benefits

NovoRapid insulin aspart acts quickly at mealtimes, helping match insulin to food intake. The rapid onset supports flexible dosing around meals when guided by a clinician. The vial format can be practical for those who prefer syringes, need small dose adjustments, or use insulin pumps that are filled from a vial.

As a U-100 standard formulation, the NovoRapid 100 units/mL vial works with widely available U-100 syringes. Many patients appreciate the predictable mealtime action and the ability to coordinate doses with carbohydrate intake.

Side Effects and Safety

• Low blood sugar (shakiness, sweating, dizziness, headache, fast heartbeat).
• Injection site reactions such as redness, swelling, or itching.
• Skin changes at injection sites, including lipodystrophy or localized thickening.
• Mild weight gain or fluid retention.
• Rash or itching.

Serious risks include severe hypoglycemia, low potassium, and rare severe allergic reactions. Pump users can experience high blood sugar or ketoacidosis if infusion is interrupted by occlusion or disconnection. Hypoglycemia risk increases when insulin is combined with other medicines that lower glucose, including sulfonylureas. Seek urgent care for severe symptoms.

Drug Interactions and Cautions

• Medicines that may increase insulin effect: GLP-1 agonists, some oral diabetes agents, ACE inhibitors, and alcohol.
• Medicines that may reduce insulin effect: corticosteroids, some diuretics, certain antipsychotics, and sympathomimetics.
• Beta-blockers can mask fast heartbeat, a warning sign of hypoglycemia.
• Thiazolidinediones with insulin can increase fluid retention; monitor for heart failure symptoms.
• Illness, changes in activity, or diet can alter insulin needs.

Do not change the dose or timing without clinical guidance. Report recurrent low or high readings, pump issues, or new medicines to the prescriber.

What to Expect Over Time

Insulin aspart begins working quickly around meals, with an early effect soon after injection. Peak action occurs later, and the effect tapers after several hours. Dose adjustments are common during the first weeks as patterns emerge. Over time, consistent premeal dosing, carbohydrate matching, and site rotation support steady control.

For perspective on another rapid-acting analog, see the editorial comparison Novorapid vs Humalog.

Compare With Alternatives

Several rapid-acting analogs are used for mealtime coverage. Faster aspart is an option for select patients and is available as Fiasp® Vials. Insulin lispro is another established choice, offered as a Humalog® Vial. Apidra (insulin glulisine) is also an approved rapid-acting insulin. The best fit depends on individual goals, device use, and prescriber guidance.

Pricing and Access

CanadianInsulin provides Canadian pricing with US delivery from Canada. Many patients compare the NovoRapid vial price to local cash costs to manage budgets. You can review options to order NovoRapid vial online with secure checkout, or mail order refills when authorized. This branded NovoRapid insulin aspart vial is 100 units/mL in a 10 mL format.

Looking to compare costs? Check the current insulin aspart U-100 vial price and see if Canadian NovoRapid vial pricing fits the budget. It is also possible to order an insulin aspart vial 10 mL from Canada with US shipping when the prescription is verified. For occasional site offers, visit our Promotions page.

Availability and Substitutions

Availability can vary. If a NovoRapid 100 units/mL vial is not in stock, a prescriber may recommend another rapid-acting insulin aspart product or a different rapid-acting analog.

Patient Suitability and Cost Saving Tips

NovoRapid multidose vials can suit patients who make small dose adjustments, those who fill pumps, or those who prefer syringes under guidance. Those with frequent severe lows, insulin allergies, or complex comorbidities need close supervision.

• Consider multi-month supplies to reduce per-unit shipping fees.
• Set refill reminders so therapy is not interrupted.
• Discuss whether a vial versus a pen format affects overall cost and dosing flexibility.
• Review combined therapy plans, such as basal insulin plus mealtime insulin, for simplicity and adherence.

Questions to Ask Your Clinician

• What is the target timing for each mealtime injection?
• How should the dose change for higher or lower carbohydrate meals?
• Which injection sites are preferred and how often should they be rotated?
• Is pump therapy appropriate, and what are the pump’s infusion set change intervals?
• When should ketones be checked during illness or high readings?
• What is the plan for exercise days or skipped meals?
• How long can an opened vial be used under typical conditions?

Authoritative Sources

Novo Nordisk Canada

DailyMed Insulin Aspart

Health Canada DPD

Start your order for the NovoRapid vial with prompt, express, cold-chain shipping from Canada to the US.